Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Imricor Medical Systems Inc

Healthcare AU IMR

2.02AUD
0.02(1.00%)

Last update at 2026-03-11T05:10:00Z

Day Range

1.982.03
LowHigh

52 Week Range

1.112.25
LowHigh

Fundamentals

  • Previous Close 2.00
  • Market Cap638.68M
  • Volume201312
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-21.99224M
  • Revenue TTM0.29M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM -2.03353M
  • Diluted EPS TTM-0.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -26.20149M -29.69283M -22.62590M -17.35627M -19.73254M
Minority interest - - - - -
Net income -26.20149M -29.69283M -22.62590M -17.53418M -20.55611M
Selling general administrative - 4.92M 5.09M 4.98M 5.82M
Selling and marketing expenses - 2.27M 2.73M 2.80M 2.87M
Gross profit -2.10444M -0.92412M -1.11584M -1.52678M -1.89592M
Reconciled depreciation - 0.75M 0.71M 0.71M 0.69M
Ebit -23.58574M -16.29681M -22.57795M -17.17835M -19.62369M
Ebitda -22.55577M -15.54865M -21.87041M -16.46586M -18.93458M
Depreciation and amortization 1.03M 0.75M 0.71M 0.71M 0.69M
Non operating income net other - - - - -
Operating income -23.58574M -16.29681M -16.85500M -17.17835M -19.62369M
Other operating expenses 23.89M 17.26M 17.47M 18.81M 21.74M
Interest expense 0.00431M 0.02M 0.05M 0.18M 0.11M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - 0.26M 0.06M 0.11M 0.02M
Net interest income - 0.24M 0.02M -0.06992M -0.09212M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -0.00000M 0.18M 0.82M
Total revenue 0.30M 0.96M 0.62M 0.82M 0.70M
Total operating expenses 21.48M 15.37M 15.74M 16.47M 19.15M
Cost of revenue 2.41M 1.88M 1.73M 2.34M 2.59M
Total other income expense net -2.61575M -13.39602M -5.77090M -0.17792M -0.10885M
Discontinued operations - - - - -
Net income from continuing ops - -29.69283M -22.62590M -17.35627M -19.73254M
Net income applicable to common shares - -29.69283M -22.62590M -17.35627M -19.73254M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 45.79M 21.62M 12.18M 13.70M 26.86M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.80M 0.79M 1.52M 1.59M 1.51M
Total liab 34.26M 29.00M 25.00M 6.19M 4.46M
Total stockholder equity 11.53M -7.37703M -12.82827M 7.51M 22.40M
Deferred long term liab - - - - -
Other current liab 4.78M 1.55M 1.16M 0.02M 0.18M
Common stock 0.03M 0.03M 0.02M 97.47M 95.01M
Capital stock - - - 97.47M 95.01M
Retained earnings -167.71144M -142.27972M -164.99880M -89.96098M -72.60472M
Other liab - - - 0.54M 0.51M
Good will - - - - -
Other assets - - - 0.23M 0.57M
Cash 19.52M 15.71M 1.22M 5.69M 18.52M
Cash and equivalents - - - - -
Total current liabilities 17.38M 2.36M 6.70M 2.07M 2.74M
Current deferred revenue 0.03M - 0.85M 0.92M 1.35M
Net debt 7.10M 5.51M 14.48M -1.19781M -16.77856M
Short term debt 12.07M 0.47M 1.60M 0.87M 0.52M
Short long term debt - - - - -
Short long term debt total 26.62M 21.21M 15.70M 4.49M 1.74M
Other stockholder equity 179.21M 134.88M 152.15M - -
Property plant equipment - - - 3.56M 3.60M
Total current assets 42.95M 18.35M 5.77M 9.68M 22.70M
Long term investments - - - - -
Net tangible assets - - - 7.51M 22.40M
Short term investments 21.29M - - - -
Net receivables 0.24M 0.35M 0.58M 0.13M 0.09M
Long term debt - - - 2.18M -
Inventory 1.10M 1.50M 2.46M 2.28M 2.58M
Accounts payable 0.50M 0.33M 3.08M 0.26M 0.69M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.48M 0.68M 1.49M 0.46M 0.57M
Deferred long term asset charges - - - - -
Non current assets total 2.84M 3.27M 6.40M 4.02M 4.17M
Capital lease obligations - - - 2.31M 1.74M
Long term debt total - - - 2.25M 0.23M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.07498M -0.08278M -0.23886M -0.06956M
Change to liabilities - - - -0.57287M 0.24M
Total cashflows from investing activities -22.46905M -0.07498M -0.08278M -0.23886M -0.69530M
Net borrowings - -0.21373M 2.62M 1.97M -0.58130M
Total cash from financing activities 44.55M 30.33M 8.21M 3.94M 11.59M
Change to operating activities - - - 0.11M -0.60549M
Net income -26.20149M -29.69283M -22.62590M -17.53418M -19.73254M
Change in cash 2.59M 14.88M -4.85629M -12.82839M -6.62360M
Begin period cash flow 16.93M 0.83M 5.69M 18.52M 25.14M
End period cash flow 19.52M 15.71M 0.83M 5.69M 18.52M
Total cash from operating activities -19.74657M -15.57391M -12.97746M -16.82169M -17.48855M
Issuance of capital stock - 32.91M 5.85M 4.37M 12.17M
Depreciation 1.03M 0.92M 1.30M 0.71M 0.69M
Other cashflows from investing activities -22.01962M 0.00300M - 0.00000M -0.06956M
Dividends paid - - - - -
Change to inventory -0.13437M 0.45M -0.91945M -0.44497M -0.18136M
Change to account receivables 0.16M 0.07M -0.21625M -0.06822M 0.15M
Sale purchase of stock -1.35882M -1.90590M -0.08527M -0.07067M 12.17M
Other cashflows from financing activities - 31.00M -0.17125M 0.51M -0.58130M
Change to netincome - - - 1.01M 1.94M
Capital expenditures 0.45M 0.08M 0.08M 0.24M 0.63M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.10450M 1.20M 2.87M -0.97767M -0.38914M
Stock based compensation - 0.07M - - -
Other non cash items 5.53M 12.92M 6.78M 16.82M 19.04M
Free cash flow -20.19600M -15.65189M -13.06024M -17.06055M -18.11429M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IMR
Imricor Medical Systems Inc		 0.02 1.00% 2.02 - - 2184.96 39.12 1491.42 -2.6027
COH
Cochlear Ltd		 0.89 0.49% 183.41 35.04 28.33 5.17 6.50 5.41 22.39
4DX
4DMEDICAL Ltd		 -0.05 1.13% 4.38 - - 421.18 37.59 411.50 -7.2899
AVR
Anteris Technologies Global Corp		 0.27 3.14% 8.86 - - 495.24 162.25 283.45 -5.1986
PNV
Polynovo Ltd		 0.05 5.56% 0.95 92.50 30.40 4.58 7.52 4.45 89.43

Reports Covered

Stock Research & News

View All

Profile

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Imricor Medical Systems Inc

400 Gateway Boulevard, Burnsville, MN, United States, 55337

Key Executives

Name Title Year Born
Mr. Steve Wedan Pres, CEO & Exec. Chairman 1969
Mr. Gregg Stenzel Chief Operating Officer NA
Mr. Jonathon Gut CFO, Controller, Director & VP of Fin. NA
Mr. Greg Englehardt Exec. Director of Sales NA
Mr. Nick Twohy VP of Marketing & Bus. Devel. NA
Mr. Kobe Lizheng Company Sec. & Local Agent NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969
Mr. Jonathon Gut CFO, Controller, Director & VP of Finance NA
Mr. Greg Englehardt Senior Director of Sales NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.